These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 4926838)

  • 21. Abnormal mineral metabolism and mortality in hemodialysis patients with secondary hyperparathyroidism: evidence from marginal structural models used to adjust for time-dependent confounding.
    Fukagawa M; Kido R; Komaba H; Onishi Y; Yamaguchi T; Hasegawa T; Kurita N; Fukuma S; Akizawa T; Fukuhara S
    Am J Kidney Dis; 2014 Jun; 63(6):979-87. PubMed ID: 24119541
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The calcimimetic AMG 073 reduces parathyroid hormone and calcium x phosphorus in secondary hyperparathyroidism.
    Lindberg JS; Moe SM; Goodman WG; Coburn JW; Sprague SM; Liu W; Blaisdell PW; Brenner RM; Turner SA; Martin KJ
    Kidney Int; 2003 Jan; 63(1):248-54. PubMed ID: 12472790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Correlation of serum parathyroid hormone level with other parameters of secondary hyperparathyroidism in renal insufficiency].
    Loew H; Hrubesch M; Meermann R
    Med Welt; 1976 Nov; 27(47):2272-4. PubMed ID: 1004171
    [No Abstract]   [Full Text] [Related]  

  • 24. Can successful renal transplantation resolve secondary hyper-parathyroidism?
    Koyama Y; Miyazato T; Hatano T; Ogawa Y
    Transplant Proc; 1996 Jun; 28(3):1644-5. PubMed ID: 8658819
    [No Abstract]   [Full Text] [Related]  

  • 25. Intravenous paricalcitol for treatment of secondary hyperparathyroidism in children on hemodialysis.
    Greenbaum LA; Benador N; Goldstein SL; Paredes A; Melnick JZ; Mattingly S; Amdahl M; Williams LA; Salusky IB
    Am J Kidney Dis; 2007 Jun; 49(6):814-23. PubMed ID: 17533024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Posttransplant regression of uremic tumoral calcinosis].
    de Alarcón RM; Palomares M; Marfil A; Asensio C
    Nefrologia; 2007; 27(3):378-81. PubMed ID: 17725459
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Relation between Calcium, Phosphorus, Calcium-Phosphorus Index and iPTH in Chronic Kidney Disease Patients.
    Adhikary LP; Yadava SK; Pokharel A; Khadka D; Thakur R
    J Nepal Health Res Counc; 2015; 13(29):50-3. PubMed ID: 26411713
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cinacalcet for secondary hyperparathyroidism in patients receiving hemodialysis.
    Block GA; Martin KJ; de Francisco AL; Turner SA; Avram MM; Suranyi MG; Hercz G; Cunningham J; Abu-Alfa AK; Messa P; Coyne DW; Locatelli F; Cohen RM; Evenepoel P; Moe SM; Fournier A; Braun J; McCary LC; Zani VJ; Olson KA; Drüeke TB; Goodman WG
    N Engl J Med; 2004 Apr; 350(15):1516-25. PubMed ID: 15071126
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Parathyroid function in renal insufficiency.
    Corvilain J; Fuss M; De Backer M; Bergans A; Nys-Dewolf N; Manderlier T; Brauman H
    Adv Nephrol Necker Hosp; 1974; 4():171-84. PubMed ID: 4219992
    [No Abstract]   [Full Text] [Related]  

  • 30. Skeletal resistance to endogenous parathyroid hormone in pateints with early renal failure. A possible cause for secondary hyperparathyroidism.
    Llach F; Massry SG; Singer FR; Kurokawa K; Kaye JH; Coburn JW
    J Clin Endocrinol Metab; 1975 Aug; 41(2):339-45. PubMed ID: 169280
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Skeletal resistance to parathyroid hormone in renal failure. Studies in 105 human subjects.
    Massry SG; Coburn JW; Lee DB; Jowsey J; Kleeman CR
    Ann Intern Med; 1973 Mar; 78(3):357-64. PubMed ID: 4571863
    [No Abstract]   [Full Text] [Related]  

  • 32. Serum receptor activator of nuclear factor-κ B ligand, osteoprotegrin, and intact parathyroid hormone in hemodialysis and renal transplant patients.
    Rashtchizadeh N; Ghorbanihaghjo A; Argani H; Mahmoudi Meimand S; Safa J; Vatankhahan H; Shahidi M
    Ther Apher Dial; 2012 Dec; 16(6):600-4. PubMed ID: 23190522
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Parathyroid suppressibility in hyperparathyroidism due to chronic renal failure: studies with autotransplanted parathyroid tissue.
    Born W; Dambacher MA; Meyrier A; Ardaillou R; Fischer JA
    Clin Endocrinol (Oxf); 1982 Oct; 17(4):333-43. PubMed ID: 6754143
    [No Abstract]   [Full Text] [Related]  

  • 34. Disordered mineral metabolism and vascular calcification in nondialyzed chronic kidney disease patients.
    Mehrotra R
    J Ren Nutr; 2006 Apr; 16(2):100-18. PubMed ID: 16567266
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Does erythropoietin have a beneficial effect on calcium, phosphorus and parathyroid hormone levels in pediatric hemodialysis patients?
    Saatci U; Topaloglu R; Ozen S; Bakkkaloglu A; Besbas N
    Nephron; 1994; 67(3):371. PubMed ID: 7936038
    [No Abstract]   [Full Text] [Related]  

  • 36. Roentgen appearance of bone and soft tissue changes in chronic renal disease.
    Greenfield GB
    Am J Roentgenol Radium Ther Nucl Med; 1972 Dec; 116(4):749-57. PubMed ID: 4566090
    [No Abstract]   [Full Text] [Related]  

  • 37. Japanese Society of Dialysis Therapy treatment guidelines for secondary hyperparathyroidism.
    Kazama JJ
    Ther Apher Dial; 2007 Oct; 11 Suppl 1():S44-7. PubMed ID: 17976085
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperparathyroidism in patients on chronic hemodialysis.
    Savoy GM; Yium JJ; Jordan PH; Guinn GA
    Am J Surg; 1973 Dec; 126(6):755-7. PubMed ID: 4758794
    [No Abstract]   [Full Text] [Related]  

  • 39. Decreased secondary hyperparathyroidism in diabetic patients receiving hemodialysis.
    Vincenti F; Hattner R; Amend WJ; Feduska NJ; Duca RM; Salvatierra O
    JAMA; 1981 Mar; 245(9):930-3. PubMed ID: 7007680
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [The effect of decreasing serum calcium in serum during hemodialysis on PTH levels in children with end stage renal disease].
    Sieniawska M; Ziółkowska H; Pańczyk-Tomaszewska M; Weglarska J
    Pediatr Pol; 1995 Dec; 70(12):1017-22. PubMed ID: 8649940
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.